These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of guanfacine as a potential medication for alcohol use disorder in long-term drinking rats: behavioral and electrophysiological findings. Fredriksson I; Jayaram-Lindström N; Wirf M; Nylander E; Nyström E; Jardemark K; Steensland P Neuropsychopharmacology; 2015 Mar; 40(5):1130-40. PubMed ID: 25359257 [TBL] [Abstract][Full Text] [Related]
4. The GABA Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133 [TBL] [Abstract][Full Text] [Related]
5. Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats. Moorman DE; James MH; Kilroy EA; Aston-Jones G Brain Res; 2017 Jan; 1654(Pt A):34-42. PubMed ID: 27771284 [TBL] [Abstract][Full Text] [Related]
6. Effects of subunit selective nACh receptors on operant ethanol self-administration and relapse-like ethanol-drinking behavior. Kuzmin A; Jerlhag E; Liljequist S; Engel J Psychopharmacology (Berl); 2009 Mar; 203(1):99-108. PubMed ID: 18987848 [TBL] [Abstract][Full Text] [Related]
7. The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile. Vengeliene V; Moeller A; Meinhardt MW; Beardsley PM; Sommer WH; Spanagel R; Bespalov A Neuropsychopharmacology; 2016 Mar; 41(4):979-88. PubMed ID: 26216521 [TBL] [Abstract][Full Text] [Related]
8. Assessment of in vivo organ-uptake and in silico prediction of CYP mediated metabolism of DA-Phen, a new dopaminergic agent. Sutera FM; Giannola LI; Murgia D; De Caro V Comput Biol Chem; 2017 Dec; 71():63-69. PubMed ID: 28985485 [TBL] [Abstract][Full Text] [Related]
9. The monoamine stabilizer (-)-OSU6162 prevents the alcohol deprivation effect and improves motor impulsive behavior in rats. Fredriksson I; Wirf M; Steensland P Addict Biol; 2019 May; 24(3):471-484. PubMed ID: 29480646 [TBL] [Abstract][Full Text] [Related]
10. Ethanol-associated olfactory stimuli reinstate ethanol-seeking behavior after extinction and modify extracellular dopamine levels in the nucleus accumbens. Katner SN; Weiss F Alcohol Clin Exp Res; 1999 Nov; 23(11):1751-60. PubMed ID: 10591591 [TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders. Domi E; Barbier E; Augier E; Augier G; Gehlert D; Barchiesi R; Thorsell A; Holm L; Heilig M Neuropsychopharmacology; 2018 Aug; 43(9):1805-1812. PubMed ID: 29463912 [TBL] [Abstract][Full Text] [Related]
12. The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models. Aziz AM; Brothers S; Sartor G; Holm L; Heilig M; Wahlestedt C; Thorsell A Psychopharmacology (Berl); 2016 Oct; 233(19-20):3553-63. PubMed ID: 27515665 [TBL] [Abstract][Full Text] [Related]
13. A critical role of nucleus accumbens dopamine D1-family receptors in renewal of alcohol seeking after punishment-imposed abstinence. Marchant NJ; Kaganovsky K Behav Neurosci; 2015 Jun; 129(3):281-91. PubMed ID: 25914922 [TBL] [Abstract][Full Text] [Related]
14. Administration of a putative pro-dopamine regulator, a neuronutrient, mitigates alcohol intake in alcohol-preferring rats. Solanki N; Abijo T; Galvao C; Darius P; Blum K; Gondré-Lewis MC Behav Brain Res; 2020 May; 385():112563. PubMed ID: 32070691 [TBL] [Abstract][Full Text] [Related]
15. Neuropeptide S differently modulates alcohol-related behaviors in alcohol-preferring and non-preferring rats. Cannella N; Kallupi M; Li HW; Stopponi S; Cifani C; Ciccocioppo R; Ubaldi M Psychopharmacology (Berl); 2016 Aug; 233(15-16):2915-24. PubMed ID: 27235017 [TBL] [Abstract][Full Text] [Related]
16. The effects of xenon and nitrous oxide gases on alcohol relapse. Vengeliene V; Bessiere B; Pype J; Spanagel R Alcohol Clin Exp Res; 2014 Feb; 38(2):557-63. PubMed ID: 24118055 [TBL] [Abstract][Full Text] [Related]
17. Further characterization of the GlyT-1 inhibitor Org25935: anti-alcohol, neurobehavioral, and gene expression effects. Lidö HH; Jonsson S; Hyytiä P; Ericson M; Söderpalm B J Neural Transm (Vienna); 2017 May; 124(5):607-619. PubMed ID: 28161754 [TBL] [Abstract][Full Text] [Related]
18. Involvement of dopamine D2 receptors in addictive-like behaviour for acetaldehyde. Brancato A; Plescia F; Marino RA; Maniaci G; Navarra M; Cannizzaro C PLoS One; 2014; 9(6):e99454. PubMed ID: 24926837 [TBL] [Abstract][Full Text] [Related]
19. The effects of dopamine D4 receptor ligands on operant alcohol self-administration and cue- and stress-induced reinstatement in rats. Kim A; Di Ciano P; Pushparaj A; Leca J; Le Foll B Eur J Pharmacol; 2020 Jan; 867():172838. PubMed ID: 31794709 [TBL] [Abstract][Full Text] [Related]
20. The effects of lamotrigine on alcohol seeking and relapse. Vengeliene V; Heidbreder CA; Spanagel R Neuropharmacology; 2007 Dec; 53(8):951-7. PubMed ID: 17976664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]